| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |